G1G Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Zelira Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 0.3 EUR Market Closed

Market Cap: €3.4m

Z	Zelira Therapeutics Ltd F:G1G	AU
	Chord Energy Corp NASDAQ:CHRD	US
	Syntec Optics Holdings Inc NASDAQ:OPTX	US
	Dof ASA OSE:DOF	NO
M	Multi Garam Utama Tbk PT IDX:FOLK	ID
M	Matba Rofex SA BCBA:MTR	AR
	Spark VC Alternatywna Spolka Inwestycyjna SA F:8N2	PL
X	Xtacy Therapeutics Corp CNSX:XTCY	CA
M	Moovly Media Inc F:0PV2	CA

Profitability Summary

Zelira Therapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-1 171%

Negative 3Y Average Gross Margin

-269%

Declining Gross Margin

34% > -1 171%

Negative Operating Margin

-378 243%

Negative 3Y Average Operating Margin

-98 021%

Declining Operating Margin

-1 065% > -378 243%

Negative Net Margin

-518 271%

Negative 3Y Average Net Margin

-142 714%

Declining Net Margin

-1 011% > -518 271%

Negative Free Cash Flow Margin

-700 986%

Negative 3Y Average Free Cash Flow Margin

-179 717%

Declining Free Cash Flow Margin

-1 315% > -700 986%

Exceptional ROE

81%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

203%

ROIC is Increasing

-18% > 549%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.